StockNews.com started coverage on shares of Core Laboratories (NYSE:CLB – Get Rating) in a research note published on Thursday. The brokerage issued a hold rating on the oil and gas company’s stock.
A number of other brokerages have also recently issued reports on CLB. Citigroup upped their price target on shares of Core Laboratories from $21.00 to $26.00 and gave the stock a neutral rating in a research note on Tuesday, February 7th. Bank of America upgraded shares of Core Laboratories from an underperform rating to a neutral rating in a report on Monday, January 9th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, the stock has an average rating of Hold and a consensus price target of $21.83.
Core Laboratories Price Performance
CLB stock opened at $20.08 on Thursday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.47 and a current ratio of 2.05. The firm has a 50 day moving average price of $24.15 and a 200-day moving average price of $20.54. Core Laboratories has a 52-week low of $13.19 and a 52-week high of $34.08. The firm has a market capitalization of $936.33 million, a price-to-earnings ratio of 48.98 and a beta of 2.65.
Core Laboratories Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, March 6th. Shareholders of record on Monday, February 13th were paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.20%. The ex-dividend date of this dividend was Friday, February 10th. Core Laboratories’s dividend payout ratio is currently 9.76%.
Institutional Trading of Core Laboratories
Large investors have recently made changes to their positions in the stock. Raymond James & Associates purchased a new stake in Core Laboratories in the first quarter worth approximately $1,980,000. US Bancorp DE boosted its stake in shares of Core Laboratories by 15.3% in the 1st quarter. US Bancorp DE now owns 5,945 shares of the oil and gas company’s stock worth $188,000 after buying an additional 790 shares during the last quarter. Citigroup Inc. boosted its stake in shares of Core Laboratories by 57.8% in the 1st quarter. Citigroup Inc. now owns 39,192 shares of the oil and gas company’s stock worth $1,240,000 after buying an additional 14,354 shares during the last quarter. Rhumbline Advisers grew its holdings in shares of Core Laboratories by 9.4% in the first quarter. Rhumbline Advisers now owns 68,839 shares of the oil and gas company’s stock worth $2,177,000 after acquiring an additional 5,931 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in Core Laboratories by 14.0% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 39,895 shares of the oil and gas company’s stock valued at $1,262,000 after acquiring an additional 4,909 shares during the last quarter. 97.44% of the stock is currently owned by institutional investors.
About Core Laboratories
Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the Reservoir Description segment and Production Enhancement segment. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products.
See Also
- Get a free copy of the StockNews.com research report on Core Laboratories (CLB)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.